The U.S. Supreme Court gave Bayer AG a mixed reception on its bid to stop tens of thousands of lawsuits claiming its Roundup herbicide should have been labeled as a cancer risk. Hearing arguments in Washington Monday, the justices weighed …
Source: Claims Journal